Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2005 Jun; 48(3):423-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents, Phytogenic
Camptothecin
Disease Progression
Female
Heart Neoplasms
Humans
Infusions, Intravenous
Mesothelioma
Middle Aged
Peritoneal Neoplasms
Pleural Neoplasms
Survival Analysis
Treatment Outcome
authors with profiles
Hedy Kindler